Peptide Initiative

Peptides · Peptide comparison

Adrenomedullin vs Intermedin (Adrenomedullin-2)

A powerful vasodilatory peptide that relaxes blood vessels and helps your body maintain healthy fluid balance and blood pressure.

A powerful peptide hormone that protects your heart and blood vessels while managing stress and inflammation naturally.

  • Healing & Recovery
  • Healing & Recovery

At a glance

Quick comparison

Dose rangeAdrenomedullin10–10 ng/kg/minIntermedin (Adrenomedullin-2)As prescribed–As prescribed mg
FrequencyAdrenomedullinOnce dailyIntermedin (Adrenomedullin-2)Once daily
AdministrationAdrenomedullinIntravenous infusionIntermedin (Adrenomedullin-2)As directed by healthcare provider
Cycle lengthAdrenomedullinOngoing/indefiniteIntermedin (Adrenomedullin-2)Ongoing/indefinite
Onset speedAdrenomedullinModerate (1-2 weeks)Intermedin (Adrenomedullin-2)Moderate (1-2 weeks)
Evidence levelAdrenomedullinModerate human trials (Phase 1-2)Intermedin (Adrenomedullin-2)Limited human trials

Efficacy

Benefit ratings

Cardiovascular Support

Adrenomedullin82%
Intermedin (Adrenomedullin-2)No recorded rating

Tissue Protection

Adrenomedullin78%
Intermedin (Adrenomedullin-2)No recorded rating

Immune Function

Adrenomedullin74%
Intermedin (Adrenomedullin-2)No recorded rating

Cardiovascular Health & Protection

AdrenomedullinNo recorded rating
Intermedin (Adrenomedullin-2)72%

Stress & Anxiety Management

AdrenomedullinNo recorded rating
Intermedin (Adrenomedullin-2)68%

Anti-Inflammatory & Antioxidant Support

AdrenomedullinNo recorded rating
Intermedin (Adrenomedullin-2)64%

Technical data

Compound specifications

Adrenomedullin

Molecular formula
C264H406N80O77S3
Molecular weight
6029 Da (Daltons)
Half-life
Approximately 20-30 minutes in plasma (rapid metabolism)
Bioavailability
Parenteral administration only; peptide undergoes proteolytic cleavage in circulation
CAS number
148498-78-6

Intermedin (Adrenomedullin-2)

Molecular formula
C15H25NO5 (precursor compound)
Molecular weight
299.36 g/mol (precursor)
Half-life
Approximately 2-6 hours (varies by route of administration)
Bioavailability
Varies by route of administration
CAS number
148498-78-6

Protocols

Dosing compared

Adrenomedullin

Intravenous

  • 5 ng/kg/minContinuous infusion, 8 hours per day · 14 days (trial protocol)Adrenomedullin is given as a slow drip into a vein in clinical trials, not by self-injection. This low dose was the bottom step tested for steroid-resistant ulcerative colitis. [4]
  • 10 ng/kg/minContinuous infusion, 8 hours per day · 14 days (trial protocol)Middle dose tested in the ulcerative colitis trial. [4]
  • 15 ng/kg/minContinuous infusion, 8 hours per day · 14 days (trial protocol)This higher dose was the only one that significantly improved disease scores in the trial. The same 15 ng/kg/min rate was also tested safely in healthy volunteers. [4][5]

Intermedin (Adrenomedullin-2)

No dose levels recorded.

Applications

Best suited for

Adrenomedullin

Cardiovascular health optimization
Adrenomedullin is particularly well-suited for individuals focused on cardiovascular health optimization. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Maintaining healthy blood pressure
Adrenomedullin is particularly well-suited for individuals focused on maintaining healthy blood pressure. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Recovery from illness or sepsis
Adrenomedullin is particularly well-suited for individuals focused on recovery from illness or sepsis. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Tissue protection and oxygen delivery
Adrenomedullin is particularly well-suited for individuals focused on tissue protection and oxygen delivery. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

Intermedin (Adrenomedullin-2)

Supporting cardiovascular health and heart function
Intermedin (Adrenomedullin-2) is particularly well-suited for individuals focused on supporting cardiovascular health and heart function. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Managing inflammation and oxidative stress
Intermedin (Adrenomedullin-2) is particularly well-suited for individuals focused on managing inflammation and oxidative stress. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Improving overall vascular health and circulation
Intermedin (Adrenomedullin-2) is particularly well-suited for individuals focused on improving overall vascular health and circulation. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

Safety profile

Side effects

Adrenomedullin

Common

  • Mild discomfort at treatment site
  • Excessive blood pressure lowering (hypotension)
  • Headaches (from pressure changes)
  • Flushing and mild facial redness
  • Dizziness or lightheadedness
  • Mild electrolyte shifts
  • Localized injection site reactions
  • Increased urination (natriuretic effect)

Serious

  • Severe allergic reaction

Intermedin (Adrenomedullin-2)

Common

  • Mild discomfort at treatment site
  • Flushing and mild facial redness
  • Dizziness or lightheadedness
  • Mild headache
  • Injection site reactions (redness, itching, swelling)
  • Nausea or mild gastrointestinal discomfort
  • Fatigue or mild energy changes
  • Transient hypotension (temporary low blood pressure)
  • Mild palpitations (in some individuals)

Serious

  • Severe allergic reaction

Research status

Safety & evidence

Adrenomedullin

Evidence level
Moderate human trials (Phase 1-2)
FDA status
Research compound
Safety overview
Adrenomedullin safety in humans is poorly characterized, with clinical data limited to observational studies and small uncontrolled trials in cardiovascular patients. Animal studies demonstrate potent vasodilatory effects that could lower blood pressure dangerously, particularly in patients on antihypertensive medications. No human pharmacokinetic studies have established safe doses, and potential for hypotension, electrolyte disturbances, and off-target vasodilation effects exists. The peptide crosses the blood-brain barrier and affects central nervous system function in animal models, raising concerns about neurological effects at higher doses.

Contraindications

  • Severe hypotension or shock states
  • Concurrent use with certain vasopressor medications
  • Pregnancy and breastfeeding
  • Severe kidney or liver dysfunction

Intermedin (Adrenomedullin-2)

Evidence level
Limited human trials
FDA status
Not FDA approved
Safety overview
Intermedin (Adrenomedullin-2) is an endogenous peptide hormone with systemic vascular and renal effects that warrant cautious use. As a vasodilator acting through CGRP and other peptide receptors, it can significantly lower blood pressure—a key safety consideration for hypotensive or cardiovascular-compromised individuals. Preclinical studies show dose-dependent hypotensive effects and tachycardia, limiting clinical translation. The compound remains largely experimental with limited safety data in humans outside specific research contexts.

Contraindications

  • Pregnancy and breastfeeding - insufficient safety data
  • Active cardiovascular events (heart attack, stroke)
  • Severe renal (kidney) impairment
  • Hypersensitivity to calcitonin family peptides
  • Uncontrolled endocrine disorders

Decision guide

Which is right for you?

Adrenomedullin

Choose Adrenomedullin if…

  • Cardiovascular health optimization
  • Maintaining healthy blood pressure
  • Recovery from illness or sepsis
  • Tissue protection and oxygen delivery

Intermedin (Adrenomedullin-2)

Choose Intermedin (Adrenomedullin-2) if…

  • Supporting cardiovascular health and heart function
  • Managing inflammation and oxidative stress
  • Improving overall vascular health and circulation